Rockwell Medical Files 8-K on Financials
Ticker: RMTI · Form: 8-K · Filed: Mar 21, 2024 · CIK: 1041024
| Field | Detail |
|---|---|
| Company | Rockwell Medical, Inc. (RMTI) |
| Form Type | 8-K |
| Filed Date | Mar 21, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Rockwell Medical dropped its 8-K, check the financials.
AI Summary
On March 21, 2024, Rockwell Medical, Inc. filed an 8-K report detailing its financial results and condition. The filing includes financial statements and exhibits, providing an update on the company's operational and fiscal performance.
Why It Matters
This 8-K filing provides investors with crucial, up-to-date information on Rockwell Medical's financial health and operational performance, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Rockwell Medical, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 38-3317208 (identifier) — IRS Employer Identification No.
- 30142 S. Wixom Road, Wixom, Michigan 48393 (address) — Principal executive office address
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Rockwell Medical, Inc.'s results of operations and financial condition, and to provide financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on March 21, 2024.
What is Rockwell Medical, Inc.'s state of incorporation?
Rockwell Medical, Inc. is incorporated in Delaware.
What is the IRS Employer Identification Number for Rockwell Medical, Inc.?
The IRS Employer Identification Number for Rockwell Medical, Inc. is 38-3317208.
Where are Rockwell Medical, Inc.'s principal executive offices located?
Rockwell Medical, Inc.'s principal executive offices are located at 30142 S. Wixom Road, Wixom, Michigan 48393.
Filing Stats: 515 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-03-21 06:15:43
Key Financial Figures
- $0.0001 — h registered Common Stock, par value $0.0001 RMTI Nasdaq Capital Market Indicate
Filing Documents
- tm249327d1_8k.htm (8-K) — 25KB
- tm249327d1_ex99-1.htm (EX-99.1) — 126KB
- tm249327d1_ex99-1img001.jpg (GRAPHIC) — 14KB
- 0001104659-24-036897.txt ( ) — 352KB
- rmti-20240321.xsd (EX-101.SCH) — 3KB
- rmti-20240321_lab.xml (EX-101.LAB) — 33KB
- rmti-20240321_pre.xml (EX-101.PRE) — 22KB
- tm249327d1_8k_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On March 21, 2024, Rockwell Medical, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2023. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. As provided in General Instruction B.2 of Form 8-K, the information in this Item 2.02 and Exhibit 99.1 incorporated in this Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits The following exhibit is being furnished herewith: EXHIBIT INDEX Exhibit No. Description 99.1 Press Release dated March 21, 2024 104 Cover Page Interactive Data File, formatted in INline XBRL and included as Exhibit 101. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ROCKWELL MEDICAL, INC. Date: March 21, 2024 By: /s/ Mark Strobeck Mark Strobeck Chief Executive Officer